Published in Circulation on February 06, 2001
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest (2007) 2.12
The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol (2001) 2.10
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci U S A (2004) 2.07
Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol (2006) 1.82
Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci (2012) 1.76
Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res (2009) 1.65
The transcription factor GATA-6 regulates pathological cardiac hypertrophy. Circ Res (2010) 1.32
Differential expression of microRNAs in different disease states. Circ Res (2012) 1.30
Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2011) 1.23
Pulmonary hypertension-induced GATA4 activation in the right ventricle. Hypertension (2010) 1.17
Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression. J Physiol (2003) 1.12
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol (2013) 1.00
Cell signaling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis. Cell Signal (2011) 0.96
GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res (2012) 0.90
Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy. Curr Cardiol Rev (2011) 0.86
(Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function. PLoS One (2012) 0.81
Brain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure. Indian J Clin Biochem (2007) 0.80
WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function. PLoS One (2015) 0.77
Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5. PLoS One (2015) 0.75
Identification and visualization of stimulus-specific transcriptional activity in cardiac hypertrophy in mice. Int J Cardiovasc Imaging (2013) 0.75
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci U S A (2001) 2.26
Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther (1989) 1.73
Endothelin-1 signalling controls early embryonic heart rate in vitro and in vivo. Acta Physiol (Oxf) (2013) 1.40
Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology (1993) 1.35
Natriuretic peptides and mortality after stroke. Stroke (2005) 1.29
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (2001) 1.23
Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors. J Auton Pharmacol (1986) 1.19
Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med (2001) 1.14
Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol (Copenh) (1984) 1.05
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma. Eur J Haematol (1999) 1.02
Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation (1998) 1.00
Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol (2001) 0.98
B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med (1998) 0.96
Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol (1994) 0.94
Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Acta Physiol (Oxf) (2010) 0.94
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. J Intern Med (2002) 0.92
Atrial natriuretic peptide (ANP) in rat gastrointestinal tract. FEBS Lett (1988) 0.92
Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology (1993) 0.92
Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J (1987) 0.92
Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology (2000) 0.92
Cardiac mechanotransduction: from sensing to disease and treatment. Trends Pharmacol Sci (2001) 0.91
Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187. Biochem Biophys Res Commun (1985) 0.91
Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids. Biochem Biophys Res Commun (1985) 0.90
Postoperative pain relief in children. A comparison between caudal bupivacaine and intramuscular diclofenac sodium. Anaesthesia (1994) 0.90
Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. J Pharmacol Exp Ther (1986) 0.90
Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J Mol Med (Berl) (1998) 0.90
Pregnane X receptor agonists impair postprandial glucose tolerance. Clin Pharmacol Ther (2013) 0.88
Block of stretch-activated atrial natriuretic peptide secretion by gadolinium in isolated rat atrium. J Physiol (1994) 0.88
Comparison of ear tattoo, ear notching and microtattoo in rats undergoing cardiovascular telemetry. Lab Anim (2011) 0.88
Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise. Circulation (1989) 0.88
Atrial natriuretic peptide, renin activity, aldosterone, urine volume and electrolytes during a 24-h sleep-wake cycle in man. Acta Physiol Scand (1990) 0.88
Increase in atrial pressure releases atrial natriuretic peptide from isolated perfused rat hearts. Pflugers Arch (1986) 0.87
Endothelin peptides: biological activities, cellular signalling and clinical significance. Ann Med (1992) 0.87
GATA4 mediates activation of the B-type natriuretic peptide gene expression in response to hemodynamic stress. Endocrinology (2001) 0.86
A novel cardiac hormone related to A-, B- and C-type natriuretic peptides. Endocrinology (1998) 0.86
Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine. Peptides (2001) 0.86
The phorbol ester induced atrial natriuretic peptide secretion is stimulated by forskolin and Bay K8644 and inhibited by 8-bromo-cyclic GMP. Biochem Biophys Res Commun (1986) 0.85
Epidural versus intravenous fentanyl for reducing hormonal, metabolic, and physiologic responses after thoracotomy. Anesthesiology (1993) 0.85
Radioimmunoassay of plasma ouabain in healthy and pregnant individuals. J Endocrinol (2000) 0.85
Inotropic effect of adrenomedullin in the isolated perfused rat heart. Acta Physiol Scand (1996) 0.84
Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology (1994) 0.84
Plasma levels of endothelin-1 and atrial natriuretic peptide in men during a 2-hour stay in a cold room. Acta Physiol Scand (1991) 0.83
Passive mechanical stretch releases atrial natriuretic peptide from rat ventricular myocardium. Circ Res (1992) 0.83
Relaxin stimulates atrial natriuretic peptide secretion in perfused rat heart. J Endocrinol (1996) 0.83
Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. J Appl Physiol (1985) (1999) 0.83
Osteoclast recruiting activity in bone matrix. Bone Miner (1994) 0.82
Xylazine-induced sedation in chicks is inhibited by opiate receptor antagonists. Eur J Pharmacol (1984) 0.82
Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction. Ultrasound Obstet Gynecol (2007) 0.82
Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction. Am Heart J (1994) 0.82
Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. Clin Sci (Lond) (2001) 0.82
Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br J Pharmacol (1993) 0.82
Endothelin stimulates basal and stretch-induced atrial natriuretic peptide secretion from the perfused rat heart. Endocrinology (1990) 0.81
Atrial natriuretic factor determinations and chronic sodium homeostasis. Kidney Int (1986) 0.81
Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions. Eur J Cardiothorac Surg (2002) 0.81
Phorbol esters enhance stretch-induced atrial natriuretic peptide secretion. Endocrinology (1990) 0.81
Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol (2000) 0.81
Endothelin-induced atrial natriuretic peptide release from cultured neonatal cardiac myocytes: the role of extracellular calcium and protein kinase-C. Endocrinology (1992) 0.80
Changes in natriuretic peptides, apelin and adrenomedullin after off-pump and on-pump coronary artery bypass surgery. J Cardiovasc Surg (Torino) (2008) 0.80
The regulation of serum sodium after replacing carbamazepine with oxcarbazepine. Epilepsia (2001) 0.80
Therapeutic applications of drugs acting on alpha-adrenoceptors. Ann Clin Res (1988) 0.80
Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men. Heart (2009) 0.80
Norcocaine is a potent modulator of haemodynamic responses, plasma catecholamines and cardiac hormone release in conscious rats. Toxicology (1998) 0.80
Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo. Pharmacol Res (2001) 0.80
Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology (1995) 0.80
Inhibition of atrial wall stretch-induced cardiac hormone secretion by lavendustin A, a potent tyrosine kinase inhibitor. Endocrinology (1999) 0.80
Induction of cardiac natriuretic peptide gene expression in rats trained in hypobaric hypoxic conditions. Am J Physiol (1997) 0.80
No evidence for ischemic preconditioning during repeated vessel occlusion in coronary angioplasty. Int J Cardiol (1996) 0.80
Temperature has a major influence on cardiac natriuretic peptide in salmon. J Physiol (2001) 0.79
The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors. Br J Pharmacol (2010) 0.79
Natriuretic peptides stimulate steroidogenesis in the fetal rat testis. Biol Reprod (2001) 0.79
Comparison of the effects of supplementation with whey mineral and potassium on arterial tone in experimental hypertension. Cardiovasc Res (1998) 0.79
Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release. Circ Res (1997) 0.79
Effect of ryanodine on atrial natriuretic peptide secretion by contracting and quiescent rat atrium. Pflugers Arch (1994) 0.79
Human pericardial fluid contains the highest amount of endothelin-1 of all mammalian biologic fluids thus far tested. J Cardiovasc Pharmacol (1995) 0.79